Approval (2017) Compounding when drugs are on FDAs drug shortages list (August 08, 2025) FDA Clarifies Policies For Compounders As National GLP-1 Supply Begins To Stabilize (April 28, 2025) FDAs concerns with unapproved GLP-1 drugs used for weight loss (September 05, 2025) Semaglutide: Double-edged Sword with Risks and Benefits (February 3, 2025)
A pilot study investigating changes in the human plasma and urine NAD + metabolome during a 6 hour intravenous infusion of NAD +
It is not a treatment plan, not a recommendation to use these compounds, and not a substitute for evaluation by a qualified clinician
Bag #2 delivers pure NAD+, fueling mitochondrial efficiency, mental clarity, and cellular repair
It is important to discuss the expectations for your specific situation with your surgeon pre-operatively